Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wallwork

Showing results (191-200 of 365) with videos related to

Pageof 37
Sort By:
Transplantation|February 27, 1996
Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factorsL D Sharples, M Tamm, K McNeil, et al.
Lancet (London, England)|July 23, 1988
Heart-lung transplantation for cystic fibrosisJ Scott, T Higenbottam, J Hutter, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1989
Heart-lung transplantation at Papworth HospitalJ A Hutter, J P Scott, P Deespins, et al.
Transplantation Proceedings|October 1, 1991
Outcome of organs shared in the "domino" procedureD Aravot, J Scott, P Mullins, et al.
Thorax|October 1, 1988
Clinical experience in the management of pulmonary opportunist infection and rejection in recipients of heart-lung transplantsA R Penketh, T W Higenbottam, J Hutter, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1994
A comparison of the performance of pig hearts perfused with pig or human blood using an ex-vivo working heart modelJ J Dunning, R N Pierson, P C Braidley, et al.
Lancet (London, England)|May 2, 1987
Absence of electrochemical defect of cystic fibrosis in transplanted lungE W Alton, J Batten, M Hodson, et al.
Journal of Cardiovascular Pharmacology|June 1, 1987
Analysis of responses to a selective phosphodiesterase III inhibitor, SK&F 94120, on isolated myocardium, including human ventricular myocardium from "end-stage" failure patientsR W Gristwood, T A English, J Wallwork, et al.
British Heart Journal|August 1, 1976
Proceedings: Early closure of ventricular septal defect complicating myocardial infarctionK G Davidson, J Wallwork, H C Miller, et al.
Therapeutic Drug Monitoring|March 2, 1999
Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipientsA Trull, L Steel, L Sharples, et al.
Pageof 37

Showing results (191-200 of 365) with videos related to

Sort By:
Pageof 37
Transplantation|February 27, 1996
Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factorsL D Sharples, M Tamm, K McNeil, et al.
Lancet (London, England)|July 23, 1988
Heart-lung transplantation for cystic fibrosisJ Scott, T Higenbottam, J Hutter, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1989
Heart-lung transplantation at Papworth HospitalJ A Hutter, J P Scott, P Deespins, et al.
Transplantation Proceedings|October 1, 1991
Outcome of organs shared in the "domino" procedureD Aravot, J Scott, P Mullins, et al.
Thorax|October 1, 1988
Clinical experience in the management of pulmonary opportunist infection and rejection in recipients of heart-lung transplantsA R Penketh, T W Higenbottam, J Hutter, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1994
A comparison of the performance of pig hearts perfused with pig or human blood using an ex-vivo working heart modelJ J Dunning, R N Pierson, P C Braidley, et al.
Lancet (London, England)|May 2, 1987
Absence of electrochemical defect of cystic fibrosis in transplanted lungE W Alton, J Batten, M Hodson, et al.
Journal of Cardiovascular Pharmacology|June 1, 1987
Analysis of responses to a selective phosphodiesterase III inhibitor, SK&F 94120, on isolated myocardium, including human ventricular myocardium from "end-stage" failure patientsR W Gristwood, T A English, J Wallwork, et al.
British Heart Journal|August 1, 1976
Proceedings: Early closure of ventricular septal defect complicating myocardial infarctionK G Davidson, J Wallwork, H C Miller, et al.
Therapeutic Drug Monitoring|March 2, 1999
Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipientsA Trull, L Steel, L Sharples, et al.
Pageof 37